Subsequently, we developed a lectin-antibody enzyme-linked immunosorbent assay (ELISA) for measuring serum fucosylated Hp (Fuc-Hp) and reported that Fuc-Hp is a biomarker for several cancers, including pancreatic, colorectal, and prostate cancer [[3], [4], [5]]. Here, HP is linked to prostate carcinoma.